Sentinel Lymph Node Biopsy for Invasive Breast Cancer - ICD-10-CM Quality Payment Program Measure

Quality Measure Description High Priority Submission Methods
Sentinel Lymph Node Biopsy for Invasive Breast CancerThe percentage of clinically node negative (clinical stage T1N0M0 or T2N0M0) breast cancer patients before or after neoadjuvant systemic therapy, who undergo a sentinel lymph node (SLN) procedure.NORegistry

Linked ICD-10 Codes

The following ICD-10-CM codes are linked to the quality measure sentinel lymph node biopsy for invasive breast cancer when used as part of a patient's medical record. This Quality Measure is part of Medicare's Quality Payment Program (QPP).

ICD CodeDescriptionCategory

View All Quality Payment Program Measures